Hazard Information
Uses
Foralumab (NI-0401) is a potent, orally active human monoclonal antibody targeting the CD3. Foralumab modulates immune responses by human cells in NSG mice that were reconstituted with human hematopoietic stem cells[1].
in vivo
Foralumab (NI-0401; 0.6-250 μg; p.o.; daily, for 5 d) delays the rejection of B6Rag2?/? skin grafted onto the humanized mice[1].
Foralumab (0.6-250 μg; p.o. and i.h.; daily, for 5 d) prevents skin xenograft rejection in mice with human immune systems[1].
Foralumab (1-15 μg; p.o.; daily, for 5 d) has good bioavailability of intragastric in humanized mice[1].
| Animal Model: | Humanized NOD/SCID IL-2γc?/? mice with Skin grafts (Humanized mice: CD34+ cells are injected intra-hepatically into irradiated (0.9 Gy) NSG pups within 48 hours of birth) [1] |
| Dosage: | 15 μg |
| Administration: | Oral administration; daily, for 5 days and weekly dosing |
| Result: | Showed robust protection against graft rejection and prolongs graft survival. Reduced proliferation of CD8+ T cells and reduced release of TNF. Increased the concentration of IL-10. |
| Animal Model: | Humanized NOD/SCID IL-2γc?/? mice with Skin grafts (Humanized mice: CD34+ cells are injected intra-hepatically into irradiated (0.9 Gy) NSG pups within 48 hours of birth) [1] |
| Dosage: | 1, 5, 15, 50, and 250 μg (p.o.), 0.6 mg/kg (i.h.) |
| Administration: | Oral administration and subcutaneous injection; daily, for 5 days and weekly dosing |
| Result: | Had tolerant to autologous skin grafts in humanized mice. |
| Animal Model: | Humanized NOD/SCID IL-2γc?/? mice with Skin grafts (Humanized mice: CD34+ cells are injected intra-hepatically into irradiated (0.9 Gy) NSG pups within 48 hours of birth) [1] |
| Dosage: | 0, 5, 10, and 15 μg |
| Administration: | Oral administration and subcutaneous injection; daily, for 5 days and weekly dosing |
| Result: | Increased human Ig on the surface of CD4+ and CD8+ T cells. Had free mAb in the serum of mice |
References
[1] Ogura M, et, al. Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice. Clin Immunol. 2017 Oct;183:240-246. DOI:10.1016/j.clim.2017.07.005
Supplier
Shanghai YuanYe Biotechnology Co., Ltd.
Telephone021-61312847; 18021002903
Websitehttp://www.shyuanye.com
ShangHai Biochempartner Co.,Ltd
Telephone177-54423994 17754423994
Websitehttps://www.biochempartner.com
Guangzhou Hongyuan Chemical Co.,Ltd
Telephone 15817493340
Websitehttps://www.chemicalbook.com/ShowSupplierProductsList1222417/0_EN.htm
Wuhan Chemstan Biotechnology Co., Ltd.
Telephone027-65317797 15926423062
Websitehttp://www.chemstan.com/
TargetMol Chemicals Inc.
Telephone 4008200310
Websitehttps://www.targetmol.cn/
Biolab Reagents
Telephone18108604356
Websitehttps://www.biolabreagent.com/
Wuhan Jingkangen Biomedical Technology Co., Ltd
Telephone13720134139 086-15871494362 13720134139
Websitehttps://www.jknbiochem.com
Shanghai Yifei Biotechnology Co. , Ltd.
Telephone021-65675885 18964387627
Websitehttp://www.efebio.com
Changsha Fuzhen Biotechnology Co.，LTD
Telephone13823398779
Websitehttps://www.chemicalbook.com/supplier/25777903/
Wanxin Biotechnology (Jiaxing) Co., LTD
Telephone0573-83568680 18057391398
Website
Atagenix Laboratories
Telephone027-87008169 17762441161
Websitehttps://www.abinscience.com/
AntibodySystem Laboratories SAS
Telephone 33175446423
Websitehttp://www.antibodysystem.com
Biosynth Biological Technology (Suzhou) Co Ltd
Telephone 51288865780
Websitehttp://www.biosynth.com
Selleck Chemicals
Telephone400-668-6834
Websitehttp://www.selleckchem.com
Cell Sciences
Telephone 9785721070
Websitehttp://www.cellsciences.com
Guangzhou Chuangze Biotechnology Co., Ltd.
Telephone18312220236
Websitehttps://www.chemicalbook.com/ShowSupplierProductsList1638465/0_EN.htm
1of4
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
The What'sApp is temporarily not supported in mainland China
Cancel
Determine